verbio Vereinigte BioEnergie AI Stock Analysis
Want to see DE:VBK full AI Analyst Report?
verbio Vereinigte BioEnergie (VBK) AI Stock Analysis
verbio Vereinigte BioEnergie
(XETRA:VBK)
The score is supported primarily by improving financial performance (profitability and cash flow recovery with manageable leverage) and a constructive earnings outlook (upper-end EBITDA guidance and stronger cash generation). Offsetting this, technical signals remain weak with the stock trading well below major moving averages and negative MACD, while valuation appears only moderate with no dividend data provided.
verbio Vereinigte BioEnergie (VBK) vs. iShares MSCI Germany ETF (EWG)
- Market Cap
- EUR 1.52B
- Dividend Yield
- ―
- Average Volume (3M)
- 98.65K
- Price to Earnings (P/E)
- 14.6
- Beta (1Y)
- 0.19
- Revenue Growth
- 18.55%
- EPS Growth
- ―
- Country
- Germany
- Employees
- 1,394
- Sector
- General
- Sector Strength
- 55
- Industry
- Chemicals - Specialty
verbio Vereinigte BioEnergie Business Overview & Revenue Model
Company Description
VERBIO Vereinigte BioEnergie AG operates as a prominent producer and supplier of sustainable biofuels throughout Germany and the broader European market. The firm's diverse portfolio features products such as biodiesel, bioethanol, biomethane, bioste...
verbio Vereinigte BioEnergie Earnings Call Summary
The call was clearly positive overall. Management reported a substantial year-on-year improvement in EBITDA, a swing to positive operating and free cash flow, lower net debt, stronger biodiesel markets, and increased confidence in achieving the upper end of the EUR 210 million to EUR 250 million EBITDA guidance range. Regulatory developments in Germany and Europe, Canadian production prospects, India expansion, and potential U.S. 45Z tax credits were additional positives. Offsetting issues included lower bioethanol production, weaker European bioethanol margins, temporary North American production problems, pressure and uncertainty in greenhouse gas quota pricing, below-full utilization at some U.S. plants, and the long commissioning timeline for Bitterfeld. The highlights significantly outweighed the lowlights.
Q1-2027 Updates
Positive Updates
Negative Updates
Company Guidance
Management now expects group EBITDA for 2026, 2027 to come in at the upper end of its guidance range of EUR 210 million to EUR 250 million, with the first quarter performance not indicative for the full year run rate, a meaningful contribution from the greenhouse gas quota business, strong cash generation and a further significant reduction in net debt; it expects 2027 quota prices to be surely between EUR 400 and EUR 500, with the obligation growing by 5.5%, from EUR 12 million to EUR 17.5 million, while final 45Z guidance is expected in December and is not yet included. Management expects margins to stay on that level, with upside potential, expects to ramp both North American plants to full capacity, plans around about $30 million of investment in South Bend in 2027, expects first saleable Bitterfeld ethenolysis products at the end of November, December, and is planning to build up to 2 new plants in India.
verbio Vereinigte BioEnergie Financial Statement Overview
Summary
Financials show a clear rebound versus FY2025: TTM revenue growth (~5.1%) and improved profitability (gross margin ~18.2%, net margin ~5.3%) support recovery, leverage is modest (debt-to-equity ~0.22) with ROE back to ~13.1%, and TTM free cash flow is positive (~129m). Offsetting this, earnings and cash flow have been uneven across years (including prior negative FCF), so durability through the cycle remains a key risk.
Income Statement
71PositiveBalance Sheet
78PositiveCash Flow
66Positive| Breakdown | TTM | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.97B | 1.87B | 1.58B | 1.67B | 1.97B | 1.81B |
| Gross Profit | 358.77M | 336.50M | 37.12M | 292.45M | 381.91M | 626.92M |
| EBITDA | 243.11M | 184.83M | -54.41M | 122.92M | 242.68M | 494.81M |
| Net Income | 104.02M | 63.92M | -138.01M | 19.96M | 132.02M | 315.63M |
Balance Sheet | ||||||
| Total Assets | 1.43B | 1.37B | 1.28B | 1.38B | 1.30B | 1.13B |
| Cash, Cash Equivalents and Short-Term Investments | 89.35M | 90.30M | 64.41M | 126.70M | 170.31M | 300.50M |
| Total Debt | 187.73M | 221.34M | 268.86M | 194.20M | 189.97M | 49.39M |
| Total Liabilities | 571.52M | 552.08M | 536.78M | 449.54M | 385.36M | 310.16M |
| Stockholders Equity | 855.70M | 816.68M | 746.29M | 925.67M | 909.47M | 816.23M |
Cash Flow | ||||||
| Free Cash Flow | 129.30M | 78.37M | -117.96M | -54.38M | -177.12M | 210.15M |
| Operating Cash Flow | 215.92M | 164.56M | 13.88M | 116.78M | 26.09M | 325.03M |
| Investing Cash Flow | -74.16M | -75.27M | -120.06M | -144.90M | -266.43M | -113.62M |
| Financing Cash Flow | -123.78M | -64.08M | 49.88M | -19.53M | 112.21M | -18.48M |
verbio Vereinigte BioEnergie Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DE:VBK, the sentiment is Negative. The current price of 23.70 is below the 20-day moving average (MA) of 27.29, below the 50-day MA of 28.31, and below the 200-day MA of 31.84, indicating a bearish trend. The MACD of -0.88 indicates Positive momentum. The RSI at 33.36 is Neutral, neither overbought nor oversold. The STOCH value of 17.60 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for DE:VBK.
verbio Vereinigte BioEnergie Peers Comparison
Overall Rating
DE:FPE69Neutral
DE:BNR65Neutral
DE:EVK64Neutral
DE:VBK63Neutral
DE:WCH54Neutral
DE:LXS43Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 69Neutral | EUR 5.39B | 16.09 | 17.37% | 3.21% | 12.08% | 21.84% | |
| 65Neutral | EUR 8.47B | 22.30 | 8.53% | 3.24% | 0.32% | -8.91% | |
| 64Neutral | EUR 9.94B | 56.31 | 2.16% | 4.69% | 1.98% | 83.13% | |
| 63Neutral | EUR 1.52B | 14.63 | 13.07% | ― | 18.55% | ― | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 54Neutral | EUR 4.01B | -14.89 | -6.82% | 3.10% | ― | ― | |
| 43Neutral | EUR 1.14B | -1.71 | -18.99% | 0.76% | -3.63% | -172.43% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| DE:VBK | verbio Vereinigte BioEnergie | 23.70 | 7.12 | 42.94% | |
| DE:BNR | Brenntag AG (UK) | 58.66 | 11.98 | 25.66% | |
| DE:EVK | Evonik Industries AG | 21.32 | 8.76 | 69.69% | |
| DE:FPE | Fuchs Petrolub | 38.05 | 8.94 | 30.72% | |
| DE:LXS | Lanxess (OTC) | 13.15 | -3.29 | -20.03% | |
| DE:WCH | Wacker Chemie Ag (OTC) | 80.70 | 13.45 | 20.00% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 16, 2026
